-Masatoshi Kudo Researcher Activity Profile

Research Author Detailed Information 

Masatoshi Kudo Publication Rate By Year

Masatoshi Kudo has published 2 paper(s) in 2003, 3 paper(s) in 2004, 3 paper(s) in 2006, 35 paper(s) in 2007, 6 paper(s) in 2008, for a total of 49 research publications in total.

Masatoshi M Kudo Author Information

LAST NAME: kudo

FIRST NAME: masatoshi

INITIALS: M

AFFILIATION:

Papers

Masatoshi Kudo's Publication Record

1. A proposal of the modified liver damage classification for hepatocellular carcinoma. Year Published: 2006
Departments of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama 589-8511, Japan.
2. Case of adult genotype C HBV carrier after acute hepatitis B, losing HBsAg and acquiring HBsAb after IFN and lamivudine treatment. Year Published: 2006
Department of Gastroenterology, Kobe Asahi Hospital, 3-5-25 Bouoji-cho, Nagata-ku, Kobe 653-0801, Japan.
3. Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Year Published: 2006
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-sayama, Osaka 589-8511, Japan.
4. First attempt of boron neutron capture therapy (BNCT) for hepatocellular carcinoma. Year Published: 2007
Particle Oncology Research Center, Research Reactor Institute, Kyoto University, 2-1010, Asashiro-nishi, Kumatori-cho, Sennan-gun, Osaka, Japan. msuzuki@rri.kyoto-u.ac.jp
5. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Year Published: 2007
The Liver Cancer Study Group of Japan, Kyoto, Japan.
6. Small hepatocellular carcinoma presenting with massive metastasis in the peritoneum, mimicking sarcomatous tumor. Year Published: 2007
Department of Gastroenterology, Kobe Asahi Hospital, Kobe, Japan.
7. Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma. Year Published: 2007
Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
8. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
9. Review of current staging systems for hepatocellular carcinoma. Year Published: 2007
Departments of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
10. International comparison of treatment outcomes based on staging systems. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan.
11. Review of 4th Single Topic Conference on HCC. Hepatocellular carcinoma: International consensus and controversies. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
12. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Year Published: 2007
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kinki University School of Medicine, Ohno-Higashi, Osaka-Sayama, Japan.
13. Well-to moderately-differentiated HCC manifesting hyperattenuation on both CT during arteriography and arterial portography. Year Published: 2007
Department of Gastroenterology, Kobe Asahi Hospital, 3-5-25 Bououji-cho, Nagata-ku, Kobe 653-0801, Japan. info@kobe-asahi-hp.com
14. Case of rapidly progressed sarcomatoid hepatocellular carcinoma in a young female without risk factor. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan.
15. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan. kudo@med.kindai.ac.jp
16. Natural course of small nodular lesions with intranodular preserved portal supply in cirrhotic liver. Year Published: 2007
Division of Gastroenterology, Department of Internal Medicine, Kitano Hospital, Osaka, Japan.
17. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma. Year Published: 2007
Department of Pathophysiological and Therapeutic Science, Division of Pharmacotherapeutics, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan. mnmiura@grape.med.tottori-u.ac.jp
18. Superiority of CT arterioportal angiography to contrast-enhanced CT and MRI in the diagnosis of hepatocellular carcinoma in nodules smaller than 2 cm. Year Published: 2007
Department of Gastroenterology, Kobe Asahi Hospital, Kobe, Japan. asahi-hp@arion.ocn.ne.jp
19. Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients. Year Published: 2007
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan. kasugai-hi@mc.pref.osaka.jp
20. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography? Year Published: 2007
Department of Ultrasound, Wuhan General Hospital of the Guangzhou Military Area, Wuhan, PR China.
21. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
22. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Year Published: 2007
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
23. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan. m-kudo@med.kindai.ac.jp
24. Well-to moderately-differentiated HCC manifesting hyperattenuation on both CT during arteriography and arterial portography. Year Published: 2007
Department of Gastroenterology, Kobe Asahi Hospital, 3-5-25 Bououji-cho, Nagata-ku, Kobe 653-0801, Japan. info@kobe-asahi-hp.com
25. Case of rapidly progressed sarcomatoid hepatocellular carcinoma in a young female without risk factor. Year Published: 2007
26. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan. kudo@med.kindai.ac.jp
27. Natural course of small nodular lesions with intranodular preserved portal supply in cirrhotic liver. Year Published: 2007
Division of Gastroenterology, Department of Internal Medicine, Kitano Hospital, Osaka, Japan.
28. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma. Year Published: 2007
Department of Pathophysiological and Therapeutic Science, Division of Pharmacotherapeutics, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan. mnmiura@grape.med.tottori-u.ac.jp
29. Superiority of CT arterioportal angiography to contrast-enhanced CT and MRI in the diagnosis of hepatocellular carcinoma in nodules smaller than 2 cm. Year Published: 2007
Department of Gastroenterology, Kobe Asahi Hospital, Kobe, Japan. asahi-hp@arion.ocn.ne.jp
30. Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients. Year Published: 2007
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan. kasugai-hi@mc.pref.osaka.jp
31. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography? Year Published: 2007
Department of Ultrasound, Wuhan General Hospital of the Guangzhou Military Area, Wuhan, PR China.
32. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
33. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Year Published: 2007
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
34. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan. m-kudo@med.kindai.ac.jp
35. Effects of decorin on the expression of alpha-smooth muscle actin in a human myofibroblast cell line. Year Published: 2008
Department of Biochemistry, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan, munakata@med.kindai.ac.jp.
36. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Year Published: 2007
Kyoto University, Kyoto, Japan.
37. Case of rapidly progressed sarcomatoid hepatocellular carcinoma in a young female without risk factor. Year Published: 2007
38. A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video). Year Published: 2007
Osaka-Sayama, Japan, Hamburg, Germany.
39. Treatment of large and/or multiple hepatic malignancies: open surgical approaches of radiofrequency ablation. Year Published: 2008
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
40. Foreign body granuloma mimicking disseminated tumour recurrence after radiofrequency ablation for hepatocellular carcinoma. Year Published: 2008
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
41. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. Year Published: 2003
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Japan.
42. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. Year Published: 2003
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan.
43. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. Year Published: 2004
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan.
44. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. Year Published: 2004
Department of Internal Medicine, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama 589-8511, Japan.
45. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. Year Published: 2004
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama 589-8511, Japan.
46. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. Year Published: 2007
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayma, Osaka 589-8511, Japan. minkun@med.kindai.ac.jp
47. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Year Published: 2008
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kinki University School of Medicine, Osaka-Sayama, Japan.
48. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Year Published: 2008
Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. sueguchi@nagasaki-u.acjp
49. Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score. Year Published: 2008
Department of Gastroenterology, Kinki University School of Medicine, Osaka-Sayama, Japan.